Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Researchers unravel complicated relationship between diabetes and HCV
-
- Novel therapies offer optimism in the treatment of Prader-Willi syndrome Theresa Strong, PhD; Jennifer Miller, MD
- Drug Pipeline
- High radioactive iodine-131 exposure dose linked to aggressive thyroid cancer
- BMI increase adversely affects metabolic markers in lean young adults
- Congenital hypothyroidism linked to adverse pregnancy outcomes
- Diabetes during midlife increased cognitive decline in later years
- Exercise response, epigenetic profiles key in improving type 2 diabetes interventions
- Follicular fluid proteins differentially expressed in women with PCOS
-
- Glycemic index did not affect CV risk factors, insulin resistance
- Higher insulin dosage for type 2 diabetes may increase mortality risk
- Hypoglycemia increased risks for CV events, death in patients with diabetes on insulin
- Life expectancy, healthy years likely to diminish with obesity-related diabetes, CVD
- Overweight, obesity in black women linked to occupational sitting
- Pioglitazone, rosiglitazone did not increase bladder cancer risk in patients with type 2 diabetes
- Self-reported exercise assessments offer clue to cardiometabolic risks
- Technology-based tools, EMRs improved CVD medication adherence
-
- USPSTF finds insufficient evidence for universal vitamin D screening
- Mild CAD increased CV event risk in patients with diabetes